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Abstract 
AIM
To investigate whether human embryonic stem cells 
(hESCs) could be made to attach, grow and differentiate 
on a human Descemet’s membrane (DM).
Basic Study
Charles Hanson, Arsaell Arnarsson, Thorir Hardarson, Ann Lindgård, Mandana Daneshvarnaeini, 
Catarina Ellerström, Anita Bruun, Ulf Stenevi
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METHODS
Spontaneously differentiated hESCs were transferred 
onto a human corneal button with the endothelial layer 
removed using ocular sticks. The cells were cultured on 
a DM for up to 15 d. The genetically engineered hESC 
line expressed green fluorescent protein, which facilitated 
identification during the culture experiments, tissue 
preparation, and analysis. To detect any differentiation 
into human corneal endothelial-like cells, we analysed the 
transplanted cells by immunohistochemistry using specific 
antibodies.
RESULTS
We found transplanted cells form a single layer of cells 
with a hexagonal shape in the periphery of the DM. The 
majority of the cells were negative for octamer-binding 
transcription factor 4 but positive for paired box 6 protein, 
sodium potassium adenosine triphosphatase (NaKATPase), 
and Zona Occludens protein 1. In four of the 18 trials, 
the transplanted cells were found to express CK3, which 
indicates that the stem cells differentiated into corneal 
epithelial cells in these cases. 
CONCLUSION
It is possible to get cells originating from hESCs to 
become established on a human DM, where they grow 
and differentiate into corneal endothelial-like cells in vitro. 
Key words: Embryonic stem cells; Cornea; Descemet’s 
membrane; Endothelium; Immunohistochemistry 
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Core tip: This is the first report on the interaction between 
human embryonic stem cells (hESCs) and the inner parts 
of the human cornea. When hESCs were transplanted 
onto Descemet’s membrane (DM) in vitro we found that 
they were able to attach to and grow on DM in a single 
cell layer. Furthermore, the stem cells changed their 
morphology from small round cells to flat hexagonal 
cells. The transplanted hESCs also started to express 
the proteins paired box 6, Zona Occludens protein 1 and 
sodium potassium adenosine triphosphatase (NaKATPase), 
which also are expressed in human corneal endothelial 
cells.
Hanson C, Arnarsson A, Hardarson T, Lindgård A, Daneshvarnaeini 
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INTRODUCTION
The cornea is the first point of contact for visual stimuli 
entering the nervous system. It is responsible for 
approximately two-thirds of the refractive power of 
the eye, and its transparency and a regular shape are 
pivotal for accuracy of perception. The adult cornea 
is made up of three cellular layers, the epithelium, 
stroma, and endothelium, separated by two basement 
membranes, Bowman’s and Descemet’s membrane 
(DM). From both a physiological and a pathological 
perspective, the endothelium is the most important 
corneal layer. The single layer of hexagonal cells that 
makes up the endothelium is in direct contact with 
the aqueous humour in the anterior segment of the 
eye, and preserves the transparency of the cornea 
by pumping water out of the stroma. Endothelial 
dysfunction leads to oedematous accumulation of wa-
ter in the stroma, disruption of collagen fibrils, and 
opacification of the cornea[1,2]. 
Serious corneal damage can in many cases only be 
treated with transplantation. Due to the global shortage 
of donated human tissue, there is a growing interest 
in developing stem cell technology as an alternative. 
Stem cells are undifferentiated cells that can self-renew 
and generate one or more differentiated daughter cells. 
Embryonic stem cells are considered precursor cells for 
all cells in the body, and therefore are ultimately the 
origin of all tissue. Their presence is not limited to foetal 
development, but is preserved along with precursor 
cells into adulthood. In normal or damaged adult tissue, 
stem cells maintain a balance between cell production 
and cell loss by continuously replacing older cells with 
newer ones. Human embryonic stem cells (hESCs) are 
derived from the inner cell mass of the blastocyst. They 
are pluripotent, which means that under certain specific 
circumstances they can potentially form cells of all three 
germ layers (ectoderm, mesoderm, and endoderm)[3,4]. 
hESCs can preserve this pluripotency during long-term 
culture, and hence may be useful in various scientific 
and clinical applications[5].
We have previously shown that it is possible to 
transplant pre-cultured cells derived from hESCs onto 
exposed (partly stripped from epithelial cells) Bowman’s 
membrane of the human cornea[6]. In our experiments, 
the transplanted cells attached efficiently to the me-
mbrane and were not detached by the sliding forces 
from the recipient epithelial cells during wound healing. 
Furthermore, one to four cell layers of epithelial-like cells 
were formed by the transplanted cells. Given this initial 
success in facilitating wound healing of the epithelium, 
we wanted to expand our research to include the cor-
neal endothelium. 
In the current study we attempted to get hESCs to 
differentiate into corneal endothelial-like cells in vitro on 
human corneas that had been partially or completely 
cleared of all existing endothelial cells. The overall aim 
was to further develop techniques for reconstructing the 
corneal endothelium. 
MATERIALS AND METHODS
Ethical approval and samples
The study was approved by the Ethics Committee 
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at the Universities of Gothenburg and Malmö (ap-
proval number 067-04 and M155-14). In total we 
conducted experiments on 18 corneas. In all cases, 
undifferentiated hESCs were prepared by Cellectis AB 
(Gothenburg, Sweden), using a protocol previously 
described in detail[7]. In short, hESCs of line SA121 
(Cellectis, Gothenburg, Sweden)[4] were genetically 
modified to constitutively express green fluorescent 
protein (GFP) under the human elongation factor 1-alpha 
(EF1-α) promoter. The genetically modified cell line 
had previously been characterized to confirm that the 
cells had remained pluripotent and diploid through 
the transfection procedures. This clone was used to 
facilitate the identification of the transplanted cells in 
the immunohistochemistry (IHC) analysis. 
Cell culture and transplantation 
Initially, the hESCs were cultured in Cellectis DEF-
Culture System (DEF-CS™; Cellectis AB, Sweden), 
which includes neither feeder cells nor any type of 
membrane. Before transplantation, the homogeneously 
undifferentiated hESCs were allowed to initiate 
differentiation. For this, the cells were cultured in 
KnockOut™ Dulbecco’s Modified Eagle’s Medium (D-MEM) 
with 20% knock-out serum replacement (SR) and 5% 
foetal bovine serum (FBS) (Life Technologies Europe BV), 
10 μg/mL Hygromycin (Invitrogen, Carlsbad, CA, United 
States) and 5 μmol/L of Rho-associated protein kinase 
(ROCK) inhibitor (Y-27632, Sigma-Aldrich, Stockholm, 
Sweden) for 14-22 d. On the day of the transplantation, 
the differentiation medium was removed and the cells 
were rinsed once with 1 × phosphate buffer saline (PBS) 
(Ca-/Mg-). Subsequently, the cells were disassociated 
by trypsin (TrypLE™ Express, ThermoFisher Scientific 
Company, Waltham, MA, United States) added into the 
well, and incubated in 37 ℃ for 3 min × 5 min. The well 
was gently tapped after each 5-min interval to get the cells 
to detach. The suspension was centrifuged and the cell 
pellet resuspended in 1000 μL of the same culture medium 
as used for differentiation. The final cell concentration was 
4 million cells/mL. About 120000 cells were put on each 
cornea. Human corneal tissue was obtained from patients 
undergoing penetrating keratoplasty for keratoconus or 
for corneal decompensation at Mölndal University Hospital 
in Gothenburg, Sweden. The removed corneal button, 
7.5-8.0 mm in diameter, was kept in Modified Eagle’s 
Medium (MEM) (Invitrogen, Paisley, United Kingdom) 
until the surgery was completed, and then transferred 
to the laboratory for further processing. Prior to each 
experiment, the endothelial cells were removed using 
an ocular stick (Pro-ophta ocular stick, Lohmann and 
Rauscher, Regensdorf, Germany). First using the short 
end, all fluid was removed from the surface. Then the 
cells were removed with short, gentle strokes parallel 
to the surface. By adjusting the pressure the cells were 
made to detach without causing damage to the DM. 
Repeating this motion six to eight times removed close 
to all endothelial cells. The GFP-expressing cells were 
cultured on the corneas for 10-15 d. The medium was 
changed every 2-3 d throughout the period.
Paraffin embedding and sectioning
After the 18 corneas were cultured they were fixed in 4% 
formaldehyde for 24 h and then placed in 70% ethanol 
(EtOH) until paraffin embedding. They were then em-
bedded in paraffin and tissue slides prepared using 
methods previously described[6].
Immunohistochemistry
The tissue sections were deparaffinized by sequential 
immersion in Tissue-Clear (Sakura Finetek, Tokyo, 
Japan) for 2 min × 10 min, 99% isopropanol for 2 min 
× 5 min, 95% isopropanol for 1 min × 5 min, 70% 
isopropanol for 1 min × 5 min, and distilled water for 1 
min × 5 min, after which they were gently dried.
The tissue sections were rinsed twice with PBS 
Ca-/Mg- for 5 min each time, and then treated with 
Proteinase K (Sigma-Aldrich, St. Louis, MS, United 
States) for 10 min, followed by rinsing with PBS. Next, a 
5% mixture of normal goat serum (Vector Laboratories, 
Inc., Burlingame, CA, United States) in PBS was applied 
for 30 min, after which the primary antibodies were 
applied overnight in a refrigerator. 
The tissue sections were rinsed by applying PBS for 2 
min × 5 min. The secondary antibodies used were CK3 
[mouse monoclonal antibody, AE5 (ab77869); Abcam, 
Cambridge, United Kingdom], a marker for corneal 
epithelial cells (Abcam); paired box 6 (PAX-6) [mouse 
monoclonal antibody, AD2.38 (ab78545), Abcam], 
a marker for a transcription factor important in the 
development of the eye; octamer-binding transcription 
factor 3/4 (OCT-3/4) [mouse monoclonal antibody, C-10 
(sc-5279), Santa Cruz Biotechnology, Inc., Santa Cruz, 
CA, United States], a marker for embryonic stem cell 
activity; sodium potassium adenosine triphosphatase 
(NaKATPase) [rabbit monoclonal antibody (ab58475), 
Abcam], a marker for NaKATPase pump function; and 
Zona Occludens protein 1 (ZO-1) [Guinea pig polyclonal 
antibody (NBP1-49669), Novus Biologicals, Littleton, 
CO, United States], a marker for tight junctions. 
Slides were washed in PBS Ca-/Mg- and incubated 
with a secondary antibody (Alexa Fluor® goat anti-
mouse or anti-rabbit antibody; Invitrogen, Eugene, OR, 
United States) for 2 h at room temperature and in the 
dark. The slides were then rinsed once more with PBS 
Ca-/Mg- before a small drop of mounting medium for 
fluorescence with 4’,6-diamidino-2-phenylindole (DAPI) 
(Vectashield, Vector Laboratories) was applied and 
the tissue sealed with a thin glass slide. The analysis 
was performed on a Nikon fluorescence microscope 
equipped with DAPI, tetramethylrhodamine (TRITC) 
and fluorescein isothiocyanate (FITC) filters (360, 490, 
and 570 nm).
This study was conducted in accordance with the 
tenets of the Declaration of Helsinki and with permission 
from the Ethics Committee of the University of Goth-
Hanson C et al . Embryonic stem cells on damaged corneas
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RESULTS
Morphology of transplanted hESCs 
The GFP signal was easily detected in the specimens 
harbouring stem cells, making it easy to identify the 
transplanted hESCs. In the tissue sections, it was 
obvious where the GFP-positive donor cells ended and 
the recipient cells began.
Several experiments were performed in an attempt 
to optimize the time required for culturing the hESCs 
on the donor cornea (data not shown). All of the 18 
experiments revealed hESCs attached to the donor 
cornea. Briefly, the course of events can be described 
as follows: The transplanted hESCs attached to the 
DM within 6 h, and cells started to grow in different 
directions. The cells grew as a monolayer (confirmed 
later with IHC) and eventually covered the entire 
surface of the DM. 
In all of the experiments where hESCs attached 
to the DM, they formed clusters of between one and 
eight cells in thickness. However, as they spread out 
towards the periphery, they did so in a single cell layer 
and assumed a flat form as found in intact endothelia. 
Importantly, the hESCs also lost their roundness and 
assumed a more polygonal form reminiscent of their 
intact hexagonal shape (Figure 1). Furthermore, 
sections of the cells in the single cell layer revealed 
the flattened morphology typical of endothelial cells 
(Figure 2). Expression of octamer-binding transcription 
factor 4 (OCT-4), PAX-6, NaKATPase, CK3 and ZO-1 in 
transplanted hESCs.
We found expression of octamer-binding trans-
cription factor 4 (OCT-4) in ten out of 18 trials, two with 
clear signals all over the transplanted area but the other 
eight showing a very weak signal in 5%-20% of the 
cells in multilayers. In the remaining eight trials, OCT-4 
was completely absent. The hESCs were found to 
express PAX-6 clearly in nine cases (Figure 2), weakly 
in five and not at all in four. Out of 18 experiments, 
14 were positive for NaKATPase (Figure 2); in two 
experiments we only found NaKATPase faintly expressed 
and in another two not at all. Fifteen out of 18 corneas 
were negative for CK-3, two had a weak signal and one 
was deemed positive. Expression of ZO-1 was found in 
all of the transplanted corneas (Figure 2). 
DISCUSSION
We have shown that it is possible to culture hESCs 
on partially decellularized human corneal DM, were 
they assume the form of endothelial cells and start 
expressing relevant proteins. 
The sparse OCT-4 expression in the hESCs attached 
to the DM indicates that the hESCs have started to lose 
their stem cell qualities and are beginning to adopt 
features associated with corneal endothelial cells, as 
shown by the expression of PAX-6, and NaKATPase. The 
former, PAX-6, is a non-specific indicator of development 
in the eye. The frequent NaKATPase expression seen 
in the transplanted hESCs points to high activity of the 
NaKATPase pump, as would be expected in endothelial 
cells responsible for actively maintaining the fluid 
balance within the cornea. We found no correlation bet-
ween the number of days in pre-culture and expression 
of the studied proteins. Furthermore, there were no 
correlations between the expression of OCT-4, PAX-6, 
NaKATPase, ZO-1 and CK3 and the time during which 
the cells were grown on DM.
To distinguish between corneal endothelial activity, 
on the one hand, and epithelial cells, on the other, we 
used CK3 marker for epithelial cells. As there were some 
cases that were positive for CK3, we conclude that the 
differentiation of hESCs towards corneal endothelial 
cells is not as straightforward as differentiation towards 
corneal epithelial cells. Hence, there is a need for 
further optimization of the culture system to ensure 
differentiation into corneal endothelial cells.
Although there are published studies on culturing of 
adult endothelial cells (for a review, see Mimura et al[8]) 
and on transplantation of hESC-derived, endothelial-like 
cells onto rabbit corneas[9], there are no published data 
on studies of hESCs transplanted onto human corneal 
endothelial cells. 
The knowledge of stem cell culturing (embryonic, 
A B
50 μm
Figure 1  Overview of embryonic stem cells transplanted onto Descemet’s membrane. A: Fluorescent cells derived from human embryonic stem cells; B: Outline 
of the cell walls of the same cells. Red stars mark the same cells in both photos.
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foetal, and adult stem cells) for clinical applications is 
still rudimentary. Future developments within the field of 
stem cell research will probably lead to different options 
for different applications. For the treatment of certain 
diseases, adult stem cells will be the first choice; but 
for others, embryonic or foetal stem cells will be more 
suitable. Stem cell research may in the future give us 
a toolbox of specialized cells which can be matched to 
different clinical and individual conditions. The current 
study is a step towards better understanding of how 
embryonic stem cells can contribute to improved function 
in the human cornea and to finding new treatment 
strategies for patients with corneal disorders or damage. 
We have shown that hESCs attach and grow on DM, 
Figure 2  Endothelial parts of three corneal sections: A-C, D-F, and G-I. A: Nuclei through a 4‘,6-diamidino-2-phenylindole (DAPI) filter; B: The same cells through 
a fluorescein isothiocyanate (FITC) filter [green fluorescent protein (GFP) fluorescence]; C: Expression of the tight junction protein Zona Occludens protein 1 (ZO-1) 
[tetramethylrhodamine (TRITC) filter]; D: Nuclei seen through a DAPI filter; E: GFP expression (using an FITC filter); F: Expression of sodium potassium ATPase 
(NaKATPase) (using a TRITC filter); G: Nuclei seen through a DAPI filter; H: GFP expression (FITC filter); I: Expression of the cornea-related protein paired box 6 
(PAX-6). 
5 μm
5 μm
5 μm
A B
C D
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I
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and that the cells have the potential to differentiate 
into corneal endothelial-like cells. However, further 
optimization of the process is needed. We suspect that 
the “pre-differentiation” period is key in solving the 
problem of variation obtained. It seems that just adding 
ROCK inhibitor is not sufficient for a 100% success rate 
in differentiation; other, still unknown factors may be 
used to elevate the efficiency of the differentiation into 
corneal endothelial cells.
It is possible to get cells originating from hESCs 
to establish onto a human DM where they grow, and 
differentiate into corneal endothelial-like cells in vitro.
COMMENTS
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Serious corneal damage can in many cases only be treated with transplantation. 
Because of a global shortage of donated human tissue, there is a growing interest 
in developing stem cell technology as an alternative. Human embryonic stem cells 
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Research frontiers
There are several ongoing studies on culturing adult corneal endothelial cells 
for transplantaion. Some of them seem very promising. However, hESCs would 
be a complement to these adult cells and have the advantage of being of an 
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This is the first report on the interaction between hESCs and the inner parts of the 
human cornea. When hESCs were transplanted onto the Descemet’s membrane 
(DM) in vitro the authors found that the stem cells were able to attach to 
and grow on the DM in a single cell layer. Furthermore, they changed their 
morphology from small round cells to flat hexagonal cells. The transplanted 
stem cells also started to express the proteins paired box 6, Zona Occludens 
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are also expressed in human corneal endothelial cells.
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